Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.55 |
| ▸ | GAPDH | P04406 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | SLC28A2 | O43868 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.47 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | STAT6 | P42226 | 1/20 | 0.47 |
| ▸ | PI4KA | P42356 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.47 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.47 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.47 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formycin SCHEMBL10149284 | 1.00 | HIF1A (0.55) | HIF1AGAPDHADORA3SLC28A2DPP4 | |
| SCHEMBL5071995 | 0.85 | HIF1A (0.44) | HIF1ASTAT6SMN1; SMN2SLC29A1PNP | |
| SCHEMBL10149295 | 0.82 | ATG7 (0.49) | — | |
| SCHEMBL10149280 | 0.82 | IMPDH2 (0.40) | HIF1APNP | |
| SCHEMBL865526 | 0.82 | ATG7 (0.49) | — | |
| SCHEMBL29941387 | 0.81 | YTHDC1 (0.45) | HIF1AADORA3ADORA1SLC29A1HSPA8 | |
| Formycin SCHEMBL14074914 | 0.80 | HIF1A (0.61) | HIF1AGAPDHADORA3SLC28A2DPP4 | |
| Formycin SCHEMBL15262901 | 0.80 | HIF1A (0.61) | HIF1AGAPDHADORA3SLC28A2DPP4 | |
| Formycin SCHEMBL980049 | 0.80 | HIF1A (0.61) | HIF1AGAPDHADORA3SLC28A2DPP4 | |
| SCHEMBL29941437 | 0.79 | PNP (0.41) | HIF1APNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2024-05-02 | — | — | US | claimed |
| US-11725227-B2 | Devices and methods for examining drug effects on microorganisms | ESSENLIX CORPORATION (US) | 2023-08-15 | — | — | US | claimed |
| EP-4045504-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | Ai-biopharma (FR) | 2022-08-24 | — | — | EP | claimed |
| CN-114901657-A | Antiviral and liver-targeting drugs | 人工智能生物制药公司 | 2022-08-12 | — | — | CN | claimed |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | disclosed |
| US-20260138999-A1 | REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS | BRISTOL MYERS SQUIBB CO (US) | 2026-05-21 | — | — | US | disclosed |
| US-12570676-B2 | Multifunctionalized silicon nanoparticles, process for their preparation and uses thereof in electrochemiluminescence based detection methods | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| EP-4695391-A1 | TREMS FOR USE IN CORRECTION OF MISSENSE MUTATIONS | Flagship Pioneering Innovations VI, LLC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | A-BIOPHARMA (FR) | 2026-02-03 | — | — | US | disclosed |
| US-20260027191-A1 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE | UNIV ARIZONA (US) | 2026-01-29 | — | — | US | disclosed |
| US-12527739-B2 | Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof | ALCON INC. (CH) | 2026-01-20 | — | — | US | disclosed |
| EP-2600868-B1 | COMBINATION OF A PYRROLOQUINOLINE COMPOUND AND AN AMINOGLYCODISE ANTIMICROBIAL AGENT | HELPERBY THERAPEUTICS LTD (GB) | 2022-03-09 | — | — | EP | disclosed |
| US-11267827-B2 | Multifunctionalized silicon nanoparticles, process for their preparation and uses thereof in electrochemiluminescence based detection methods | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2022-03-08 | — | — | US | disclosed |
| CN-114105916-A | RyR2 stabilizer, preparation method thereof, corresponding pharmaceutical composition and application | 深圳大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-114007695-A | As AM2Heterocyclic spiro-compounds as receptor inhibitors | 谢菲尔德大学 | 2022-02-01 | — | — | CN | disclosed |
| WO-2009099676-A1 | TYPE 5 ADENYLYL CYCLASE INHIBITORS FOR PROVIDING CARDIAC PROTECTION | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-08-13 | — | — | WO | disclosed |
| US-7368437-B1 | Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents | BAYER CROPSCIENCE AG (DE) | 2008-05-06 | — | — | US | disclosed |
| EP-1165563-B1 | BICYCLIC HETEROCYCLES, METHOD FOR PRODUCING THEM AND THEIR USE AS HERBICIDES AND PHARMACEUTICAL AGENTS | BAYER CROPSCIENCE GMBH (DE) | 2005-03-02 | — | — | EP | disclosed |
| US-4028184-A | CULTURING CORYNEBACTERIUM, ARTHROBACTER, MICROBACTERIUM | KIKKOMAN SHOYU CO., LTD. (JA) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570676-B2 | Multifunctionalized silicon nanoparticles, process for their preparation and uses thereof in electrochemiluminescence based detection methods | SELP, SELPLG, SELE | HIF1A 2360/4885GAPDH 1742/4885ADORA3 4536/4885 |
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | HAVCR2, NR1H4, NR1H3 | HIF1A 3257/4885GAPDH 3766/4885ADORA3 580/4885 |
| US-12527739-B2 | Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof | MYOC, MYO1G, MYH10 | HIF1A 2962/4885GAPDH 964/4885ADORA3 1753/4885 |
| US-20260138999-A1 | REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS | RNGTT, CDA, DCTD | HIF1A 4457/4885GAPDH 2247/4885ADORA3 100/4885 |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | HAVCR2, NR1H4, NR1H3 | HIF1A 3160/4885GAPDH 3580/4885ADORA3 558/4885 |
| US-11267827-B2 | Multifunctionalized silicon nanoparticles, process for their preparation and uses thereof in electrochemiluminescence based detection methods | SELE, SIK1, SIK2 | HIF1A 2904/4885GAPDH 1690/4885ADORA3 4775/4885 |
| US-20260027191-A1 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE | DNMT3L, DNMT3A, DNMT1 | HIF1A 4581/4885GAPDH 328/4885ADORA3 997/4885 |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | SLC10A1, HAVCR2, HDGF | HIF1A 3038/4885GAPDH 536/4885ADORA3 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.